Growth Metrics

Astrana Health (ASTH) Return on Invested Capital (2016 - 2025)

Astrana Health's Return on Invested Capital history spans 15 years, with the latest figure at 0.02% for Q3 2025.

  • For Q3 2025, Return on Invested Capital fell 6.0% year-over-year to 0.02%; the TTM value through Sep 2025 reached 0.02%, down 6.0%, while the annual FY2024 figure was 0.08%, 1.0% down from the prior year.
  • Return on Invested Capital for Q3 2025 was 0.02% at Astrana Health, down from 0.05% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.19% in Q1 2021 and bottomed at 0.06% in Q4 2021.
  • The 5-year median for Return on Invested Capital is 0.08% (2024), against an average of 0.06%.
  • The largest annual shift saw Return on Invested Capital decreased -25bps in 2021 before it increased 16bps in 2022.
  • A 5-year view of Return on Invested Capital shows it stood at 0.06% in 2021, then skyrocketed by 289bps to 0.1% in 2022, then fell by -15bps to 0.09% in 2023, then fell by -15bps to 0.08% in 2024, then plummeted by -68bps to 0.02% in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Return on Invested Capital are 0.02% (Q3 2025), 0.05% (Q2 2025), and 0.06% (Q1 2025).